GLP-1 Drugs Show Promise Beyond Weight Loss, Tackling Addiction

Emerging research suggests GLP-1 medications may help reduce cravings and compulsive behaviors.

Mar. 22, 2026 at 8:39pm

Got story updates? Submit your updates here. ›

The conversation surrounding GLP-1 medications is rapidly evolving. Initially hailed for their effectiveness in weight management and diabetes treatment, emerging evidence suggests these drugs may hold significant promise in addressing addiction and related mental health challenges. This shift is prompting a re-evaluation of how we approach not just obesity, but a range of compulsive behaviors.

Why it matters

The growing understanding of addiction as a biologically driven condition is challenging long-held beliefs about willpower. Effective medications for addictive behaviors like nicotine dependence remain inaccessible to many globally, underscoring the need for a broader approach to unhealthy compulsions.

The details

Research indicates GLP-1 drugs can influence dopamine signaling, a key component in the neurobiology of both addiction and obesity. By modulating these pathways, GLP-1s may reduce cravings and compulsive behaviors. However, a holistic approach combining pharmacological interventions with lifestyle modifications is crucial for the best results.

  • The conversation surrounding GLP-1 medications is rapidly evolving.

The players

Dr. Sam Robson

A physician at Temple Clinic in Aberdeen who emphasizes the need for structured medical programs that support long-term behavioral change when using GLP-1 medications.

Siân Williams

A London-based individual who notes the need for a 'tobacco-free generation' vision applied to unhealthy food.

Anne Williams

A London resident who emphasizes the sheer volume of highly processed foods laden with sugar, salt, and fat dominating supermarket shelves, requiring a fundamental shift in food culture.

Got photos? Submit your photos here. ›

What they’re saying

“GLP-1 medicines are remarkable tools, but the best results occur when they are integrated into structured medical programmes that support long-term behavioural change. Biology matters, but biology is not the whole story.”

— Dr. Sam Robson, Physician

“Addressing this requires a fundamental shift in food culture, encompassing better education, public information campaigns, and potentially even legislative controls.”

— Anne Williams

The takeaway

The expanding potential of GLP-1 medications highlights the need for a more comprehensive approach to addressing addiction and compulsive behaviors, one that combines pharmacological interventions with broader changes to the food environment and cultural norms.